Pranidipine
![]() | |
Names | |
---|---|
IUPAC name
methyl (2E)-phenylprop-2-en-1-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | |
Other names
2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O5-methyl O3-[(E)-3-phenylprop-2-enyl] ester | |
Identifiers | |
99522-79-9 ![]() | |
ChEMBL | ChEMBL1096842 ![]() |
ChemSpider | 4940726 ![]() |
Jmol interactive 3D | Image |
MeSH | C048161 |
PubChem | 6436048 |
UNII | 9DES9QVH58 ![]() |
| |
| |
Properties | |
C25H24N2O6 | |
Molar mass | 448.46786 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
![]() ![]() ![]() | |
Infobox references | |
Pranidipine is a calcium channel blocker. It is a long acting calcium channel antagonist of the dihydropyridine group.[1]
References
- ↑ Jin Yang, Keisuke Fukuo, Shigeto Morimoto, Tadaaki Niinobu, Toshimitsu Suhara, Toshio Ogihara (2000). "Pranidipine Enhances the Action of Nitric Oxide Released From Endothelial Cells". Hypertension 35: 82–85. doi:10.1161/01.hyp.35.1.82.
This article is issued from Wikipedia - version of the Thursday, June 25, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.